Analysts/Institutional Investor Meet/Con. Call Updates

19th August 2026 Corporate Relationship Department The Manager - Listing M/s. BSE Limited M/s. National Stock Exchange of India Ltd Mumbai 400001 Bandra (E) Mumbai 400051 Scrip Code: 524816 Scrip Code: NATCOPHARM Dear Sir/Madam, Sub: Intimation of Schedule of investors meet Ref: Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) Pursuant to Regulation 30(6) read with Para A of Part A of Schedule III of the Listing Regulations, this is to inform you that the officials of the company will be participating in the following investor meeting: Date of Time Investor / Meeting Type of Nature of Location meeting name meeting Meeting Monday, 9:30 AM to Investors meeting In-person Group Singapore 24th August 6:00 PM organised by meeting 2026 to Nuvama Wealth Wednesday, Management 26th August Limited and ICICI 2026 Securities Limited The latest investors’ presentation to be discussed has already been placed on the website of the Company i.e., https://admin.natcopharma.co.in/wp- content/uploads/2026/08/InvestorPresentation19082026.pdf The schedule of the above-mentioned meeting is subject to change, and the change may occur due to exigencies on the part of Investor / Company. No Unpublished Price Sensitive Information (UPSI) pertaining to the Company is intended to be discussed during the interactions. Kindly take the same on record. Thanking you, Yours faithfully, For NATCO Pharma Limited Ch. Venkat Ramesh Company Secretary & Compliance Officer